Invention Grant
- Patent Title: Benzodiazepine derivatives that inhibit rock
- Patent Title (中): 抑制岩石的苯二氮卓衍生物
-
Application No.: US11577444Application Date: 2005-10-18
-
Publication No.: US07888503B2Publication Date: 2011-02-15
- Inventor: Michael John Alberti , David Kendall Jung
- Applicant: Michael John Alberti , David Kendall Jung
- Applicant Address: US PA Philadelphia
- Assignee: GlaxoSmithKline LLC
- Current Assignee: GlaxoSmithKline LLC
- Current Assignee Address: US PA Philadelphia
- Agent John Lemanowicz; Kathryn L. Coulter
- International Application: PCT/US2005/037184 WO 20051018
- International Announcement: WO2006/044753 WO 20060427
- Main IPC: C07D243/14
- IPC: C07D243/14 ; A61K31/5513
Abstract:
The present invention relates to dihydrobenzodiazepine derivatives, compositions and medicaments containing the same, as well as processes for the preparation and use of such compounds, compositions and medicaments. Such dihydrobenzodiazepine derivatives are useful in the treatment of diseases associated with inappropriate ROCK kinase.
Public/Granted literature
- US20090143366A1 CHEMICAL COMPOUNDS Public/Granted day:2009-06-04
Information query
